Ardelyx, Inc. (ARDX) is a publicly traded Healthcare sector company. As of September 1, 2026, ARDX trades at $3.78 with a market cap of $983.69M and a P/E ratio of -16.37. ARDX moved +0.11% today. Year to date, ARDX is -35.16%; over the trailing twelve months it is -40.57%. Its 52-week range spans $3.21 to $8.40. Analyst consensus is strong buy with an average price target of $13.63. Rallies surfaces ARDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
8 analysts cover ARDX: 0 strong buy, 8 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $13.63.
| Metric | Value |
|---|---|
| Price | $3.78 |
| Market Cap | $983.69M |
| P/E Ratio | -16.37 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.40 |
| 52-Week Low | $3.21 |
| Volume | 1.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $450.89M |
| Net Income | $-55.70M |
| Gross Margin | 94.37% |
8 analysts cover ARDX: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.63.